Marcel Mück

Marcel Mück

Auto-generated profile, based on publicly available information

Marcel Mück

AI Health Innovation Cluster, German Cancer Research Center (DKFZ), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2024 in Nature Genetics
Verified
Journal Article
Open access
PDF file
BCBrian Clarke
Brian Clarke
EHEva Holtkamp
Eva Holtkamp
HÖHakime Öztürk
Hakime Öztürk
MMMarcel Mück
Marcel Mück
MWMagnus Wahlberg
Magnus Wahlberg
OSOliver Stegle
Oliver Stegle
Rare genetic variants can have strong effects on phenotypes, yet accounting for rare variants in genetic analyses is statistically challenging due to the limited number of allele carriers and the burden of multiple testing. While rich variant annotations promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here we propose deep rare variant association testing (DeepRVAT), a model based on set neural networks that learns a trait-agnostic gene impairment score from rare variant annotations and phenotypes, enabling both gene discovery and trait prediction. On 34 quantitative and 63 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT yields substantial gains in gene discoveries and improved detection of individuals at high genetic risk. Finally, we demonstrate how DeepRVAT enables calibrated and computationally efficient rare variant tests at biobank scale, aiding the discovery of genetic risk factors for human disease traits.

13 July 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
BCBrian Clarke
Brian Clarke
EHEva Holtkamp
Eva Holtkamp
HÖHakime Öztürk
Hakime Öztürk
MMMarcel Mück
Marcel Mück
MWMagnus Wahlberg
Magnus Wahlberg
OSOliver Stegle
Oliver Stegle
Rare genetic variants can strongly predispose to disease, yet accounting for rare variants in genetic analyses is statistically challenging. While rich variant annotations hold the promise to enable well-powered rare variant association tests, methods integrating variant annotations in a data-driven manner are lacking. Here, we propose DeepRVAT, a model based on set neural networks that learns burden scores from rare variants, annotations, and phenotypes. In contrast to existing methods, DeepRVAT yields a single, trait-agnostic, nonlinear gene impairment score, enabling both risk prediction and gene discovery in a unified framework. On 34 quantitative and 26 binary traits, using whole-exome-sequencing data from UK Biobank, we find that DeepRVAT offers substantial increases in gene discoveries and improved replication rates in held-out data. Moreover, we demonstrate that the integrative DeepRVAT gene impairment score greatly improves detection of individuals at high genetic risk. Finally, we show that pre-trained DeepRVAT scores generalize across traits, opening up the possibility to conduct highly computationally efficient rare variant tests.